Imagine a high-powered cleaning system for your air that works like a vacuum for germs, but it's hidden inside your building's ventilation. Instead of just filtering dust, it uses a special mist to kill 99.99% of viruses and bacteria while people are still in the room. It's like having a permanent, invisible shield that keeps the air fresh and safe without needing to evacuate the building.
Current air purification systems cannot effectively eliminate infectious pathogens in occupied spaces, forcing reliance on social distancing and lockdowns during outbreaks. There is a critical need for a system that kills microorganisms without harming humans.
A bio-decontamination system (Delox AIR) based on proprietary dryVHP technology that retrofits into HVAC systems to continuously kill airborne pathogens.
If you are a healthcare provider dealing with high occupancy density and vulnerable patients — this project developed a dryVHP system that kills microorganisms with 99.99% efficacy. This allows for safe patient interaction and prevents disease spread without harming humans.
If you are a facility manager dealing with the risk of workplace outbreaks and employee absenteeism — this project developed an HVAC retrofit that delivers clean, safe air. It consumes up to 20% less energy than current systems while maintaining a safe environment.
If you are a public administrator dealing with the need to keep schools or offices open during epidemics — this project developed a bio-decontamination system compatible with human presence. It removes the need for social distancing by actively eliminating pathogens from the air.
Based on available project data, specific pricing or cost per unit is not provided; however, the system is designed to consume up to 20% less energy than current systems.
Yes, the system is designed to retrofit all HVAC systems in the world, targeting a commercial air purification market estimated at €15.0 B by 2030.
The system is based on the company's proprietary dryVHP technology. Based on available project data, specific licensing terms are not disclosed.
The solution is designed to be integrated into any HVAC system via indirect sales through distributors who work with HVAC consultants and contractors.
The project period runs from 2024-07-01 to 2026-12-31, during which they will validate the system in three different closed environments.
The project is led by a single Portuguese SME, Delox, which holds 100% of the industry ratio. This lean structure suggests a fast decision-making process and a strong focus on commercializing their proprietary dryVHP technology without the complexity of a large multi-partner consortium.
Contact DELOX - INVESTIGACAO, PROCESSOS E EQUIPAMENTOS CIENTIFICOS, LDA in Portugal
Contact us to find integration partners for HVAC bio-decontamination
